Gene-editing by CRISPR-Cas9 in combination with anthracycline therapy via tumor microenvironment-switchable, EGFR-targeted, and nucleus-directed nanoparticles for head and neck cancer suppression
Chen Shen Wang, Chih Hsien Chang, Tsai Yu Tzeng, Anya Maan Yuh Lin, Yu Li Lo*
*此作品的通信作者
研究成果: Article › 同行評審
20
引文
斯高帕斯(Scopus)